Related Experiment Video
Updated: May 28, 2025

Preparation of Agar Bead Embedded Mycobacterium abscessus to Inoculate Immunocompetent Mice Intratracheally
Published on: April 25, 2025
Comprehensive Management Algorithm for Mycobacterium avium Complex Pulmonary Disease in the Real-World Setting
Kozo Morimoto1,2,3, Charles L Daley4,5
1Respiratory Disease Center and.
Managing Mycobacterium avium complex pulmonary disease (MAC-PD) is difficult due to treatment challenges. This review offers a new algorithm integrating non-drug therapies and multidisciplinary care for better patient outcomes.
Area of Science:
- Pulmonology
- Infectious Diseases
- Medical Management
Background:
- Mycobacterium avium complex pulmonary disease (MAC-PD) management is challenging due to limited treatment efficacy and adverse events.
- Current guidelines exist, but real-world adherence is often poor, preventing treatment completion.
Purpose of the Study:
- To propose a comprehensive management algorithm for MAC-PD.
- To integrate nonantimicrobial management and multidisciplinary approaches to improve patient outcomes.
Main Methods:
- Review of current guidelines and real-world challenges in MAC-PD management.
- Development of a proposed algorithm incorporating diagnosis, disease phenotyping, nonantimicrobial strategies, and tailored treatment.
- Emphasis on multidisciplinary care, patient education, and shared decision-making.
Main Results:
- Diagnostic delays are common due to nonspecific symptoms; proper phenotyping (e.g., cavitary lesions) is crucial for treatment selection.
- Nonantimicrobial management (airway clearance, nutrition, underlying condition management) is essential.
- Treatment strategies vary by severity; thrice-weekly regimens are preferred for noncavitary disease, while severe/cavitary forms may need daily therapy with aminoglycosides.
Conclusions:
- A comprehensive, multidisciplinary algorithm is proposed to address MAC-PD management challenges.
- Integrating nonantimicrobial care and shared decision-making can enhance treatment adherence and patient outcomes.
- Specialist consultation is advised for complex cases, including macrolide resistance or need for surgery.
More Related Videos
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
07:50Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Cystic Fibrosis: Management
Sinus disease and chronic...